Multiple Sclerosis Clinical Trial
Official title:
Early Cognitive Impairment in Multiple Sclerosis: a Multimodal MRI Study Evaluating the Relative Contribution of Cortical and White Matter Tract Injury
Cognitive impairment is one of the symptoms of Multiple Sclerosis (MS), and it may occur
during the first years of the disease. It usually affects attention, information processing
speed and short term memory. To date, the mechanisms of this specific symptom remain unclear
(local or global inflammation, neurodegenerative processes).
Magnetic Resonance Imaging (MRI) can be useful to understand the pathophysiology of
cognitive impairment in MS. The investigators will combine conventional and non conventional
MRI sequences to determine the respective role of white matter and grey matter injury and
the cortical reorganization of neuronal networks.
Cognitive impairment in Multiple Sclerosis (MS) occurs in 50% of patients and has a major
social impact. There is no clear correlation between cognitive dysfunction and disease
duration and recent studies have pointed out that it may affects patients at the very early
stages of the disease especially in tasks involving sustained attention, processing speed,
working memory and executive function.
Recent imaging and pathology studies have shown that MS affects white matter as well as grey
matter. Unlike white matter lesion burden or distribution, grey matter atrophy has often
been linked to cognitive impairment. Microscopic injury of Normally Appearing White Matter
(NAWM) explored by non conventional MRI sequences has also been shown to be involved in
pathophysiology of cognitive disorders.
Nevertheless mechanisms of cognitive impairment remain unclear. The relationship between
cortical injury and diffuse white matter tracts damage and their respective contribution to
cognitive dysfunction affecting patients during the first years of the disease is still
under investigation.
This study aims at investigating structural and functional correlates of early cognitive
impairment using multimodal MRI.
Relapsing Remitting MS (RRMS) patients with disease duration of less than 5 years will be
included. Patients with and without cognitive impairment will be compared to healthy
controls. All subjects will perform a clinical and neuropsychological evaluation before the
MRI examination.
We will combine new available MRI techniques using a 3 Tesla magnet in order to evaluate
precisely cortical and white matter tracts lesions in patients with cognitive MS. These
techniques will include :
- 3D T1 sequences to study cortical atrophy using VBM.
- Diffusion tensor imaging fibre tracking to study selected white matter tracts that may
be involved in cognitive disorders, such as the thalamus-cortical or the
striatum-cortical tracts connecting sub-cortical structures to the prefrontal cortex.
- Functional MRI sequences during a working memory task and during the resting state in
order to describe functional networks and their possible reorganization in patients
with or without cognitive impairment.
;
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05528666 -
Risk Perception in Multiple Sclerosis
|
||
Completed |
NCT03608527 -
Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis
|
N/A | |
Recruiting |
NCT05532943 -
Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis
|
Phase 1/Phase 2 | |
Completed |
NCT02486640 -
Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon
|
||
Completed |
NCT01324232 -
Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis
|
Phase 2 | |
Completed |
NCT04546698 -
5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
|
||
Active, not recruiting |
NCT04380220 -
Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
|
||
Completed |
NCT02835677 -
Integrating Caregiver Support Into MS Care
|
N/A | |
Completed |
NCT03686826 -
Feasibility and Reliability of Multimodal Evoked Potentials
|
||
Recruiting |
NCT05964829 -
Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis
|
N/A | |
Withdrawn |
NCT06021561 -
Orofacial Pain in Multiple Sclerosis
|
||
Completed |
NCT03653585 -
Cortical Lesions in Patients With Multiple Sclerosis
|
||
Recruiting |
NCT04798651 -
Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis
|
N/A | |
Active, not recruiting |
NCT05054140 -
Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis
|
Phase 2 | |
Completed |
NCT05447143 -
Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis
|
N/A | |
Recruiting |
NCT06195644 -
Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients
|
Phase 1 | |
Completed |
NCT04147052 -
iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis
|
N/A | |
Completed |
NCT03594357 -
Cognitive Functions in Patients With Multiple Sclerosis
|
||
Completed |
NCT03591809 -
Combined Exercise Training in Patients With Multiple Sclerosis
|
N/A | |
Completed |
NCT03269175 -
BENEFIT 15 Long-term Follow-up Study of the BENEFIT and BENEFIT Follow-up Studies
|
Phase 4 |